SHA:688062 Revenue

Mabwell (Shanghai) Bioscience had revenue of 464.67M CNY in the quarter ending September 30, 2025, with 1,717.41% growth. This brings the company's revenue in the last twelve months to 624.52M, up 268.62% year-over-year. In the year 2024, Mabwell (Shanghai) Bioscience had annual revenue of 199.78M with 56.28% growth.

Revenue (ttm)

624.52M

Revenue Growth

+268.62%

P/S Ratio

25.21

Revenue / Employee

441.05K

Employees

1,416

Market Cap

15.74B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	199.78M	71.95M	56.28%
Dec 31, 2023	127.84M	100.11M	361.03%
Dec 31, 2022	27.73M	11.50M	70.88%
Dec 31, 2021	16.23M	10.92M	206.03%
Dec 31, 2020	5.30M	-24.12M	-81.98%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Anhui Anke Biotechnology (Group)	2.58B
Tibet Cheezheng Tibetan Medicine	2.39B
Pacific Shuanglin Bio-pharmacy	2.38B
Aurisco Pharmaceutical	1.62B
Vcanbio Cell & Gene Engineering Corp.,	1.47B
Inner Mongolia Furui Medical Science	1.47B
Jinyu Bio-technology	1.33B
HitGen	498.51M

Revenue Rankings